Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347214 · ClinicalTrials.gov registry record
dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC)
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 6,260
- Enrollment target
NCT03347214 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 6,260 participants.
The verdict
NCT03347214 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 6,260 participants
- Enrollment target
Study Summary
Background: Researchers do not know much about the causes of congenital heart disease (CHD). They do know that many factors play a role. Some factors are environmental. Some are genetic. But few specific factors have been identified. And researchers do not know how many involve genes. They want to study data that has already been collected from people with CHD and their families. Objectives: To identify genetic variations related to CHD. To study molecules related to vascular disease in order to learn new ways to treat it. Eligibility: People who already participated in the Pediatric Cardiac Genomics Consortium (PCGC) study Design: Researchers will study data that was already collected in the PCGC. There will be no active participants. Researchers will get access to the data through the coordinating center. They will not download data to local storage devices. The data will have no personally identifying information....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,260 participants |
| Start Date | 2017-10-20 |
| Est. Completion | 2020-01-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03347214
The ClinicalTrials.gov registry entry for NCT03347214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03347214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03347214 about?
NCT03347214 is a clinical study titled "dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC)". Background: Researchers do not know much about the causes of congenital heart disease (CHD). They do know that many factors play a role. Some factors are environmental. Some are genetic. But few specific factors have been identified. And researchers do not know how many involve genes. They want to ...
What is the current status of trial NCT03347214?
This trial is currently completed. The enrollment target is 6,260 participants. The study started on 2017-10-20. Estimated completion is 2020-01-10.
Who is sponsoring clinical trial NCT03347214?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.